+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

DexCom Inc (DXCM) - Financial and Strategic SWOT Analysis Review

  • ID: 4267287
  • SWOT Analysis
  • 48 pages
  • GlobalData
  • Dexcom Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Abbott Diabetes Care Inc
  • Becton Dickinson and Co
  • LifeScan Inc
  • Medtronic Diabetes
  • MORE
DexCom Inc (DXCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company's operations and business divisions.
  • Corporate strategy - Analyst's summarization of the company's business strategy.
  • SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives' employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Dexcom Inc (Dexcom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring (CGM) systems. The company's major products include integrated CGM systems for adults and pediatric use, insulin pumps, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products in the North America, Asia, Latin America and the Middle East through direct sales force and a network of distributors. Dexcom is headquartered in San Diego, California, the US.

DexCom Inc Key Recent Developments

Sep 17,2019: Dexcom appoints Bridgette Heller to Board of Directors
Sep 17,2019: Dexcom promotes Quentin Blackford to Chief Operating Officer
Aug 23,2019: Court rules that the patents asserted against Dexcom CGM systems are invalid
Jul 31,2019: Dexcom reports second quarter 2019 financial results
May 01,2019: Dexcom reports first quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diabetes Care Inc
  • Becton Dickinson and Co
  • LifeScan Inc
  • Medtronic Diabetes
  • MORE
Section 1 - About the Company
  • Sonova Holding AG - Key Facts
  • Sonova Holding AG - Key Employees
  • Sonova Holding AG - Key Employee Biographies
  • Sonova Holding AG - Major Products and Services
  • Sonova Holding AG - History
  • Sonova Holding AG - Company Statement
  • Sonova Holding AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sonova Holding AG - Business Description
  • Business Segment: Cochlear Implants
  • Overview
  • Performance
  • Business Segment: Hearing Instruments
  • Overview
  • Performance
  • Geographical Segment: Americas (excluding the US)
  • Performance
  • Geographical Segment: Asia-Pacific
  • Performance
  • Geographical Segment: EMEA (excluding Switzerland)
  • Performance
  • Geographical Segment: Switzerland
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Sonova Holding AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Sonova Holding AG - Strengths
  • Sonova Holding AG - Weaknesses
  • Sonova Holding AG - Opportunities
  • Sonova Holding AG - Threats
  • Sonova Holding AG - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sonova Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Sonova Holding AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Sonova Holding AG, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 24, 2019: Global Medical Tech Companies Hamilton Bonaduz and Sonova select ANAQUA for IP Management
  • May 21, 2019: Sonova Holding: Significant acceleration in sales and profits in the second half
  • Mar 21, 2019: Semtech and Sonova create new hearing aid solutions for better IoT connectivity
  • Mar 07, 2019: Sonova to optimize local operations in selected markets
  • Feb 15, 2019: Sonova announces change to the board of directors effective as of annual general shareholders’ meeting 2019
  • Nov 20, 2018: Sonova Holding: First half results 2018/19
  • Nov 20, 2018: First half results 2018/19: Solid performance ahead of important product launch
  • Nov 16, 2018: Sonova announces changes to the management board
  • May 22, 2018: Sonova reports substantial sales and earnings growth: Full-year results 2017/18
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Sonova Holding AG, Key Facts
  • Sonova Holding AG, Key Employees
  • Sonova Holding AG, Key Employee Biographies
  • Sonova Holding AG, Major Products and Services
  • Sonova Holding AG, History
  • Sonova Holding AG, Subsidiaries
  • Sonova Holding AG, Key Competitors
  • Sonova Holding AG, Ratios based on current share price
  • Sonova Holding AG, Annual Ratios
  • Sonova Holding AG, Interim Ratios
  • Sonova Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Sonova Holding AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
  • Sonova Holding AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sonova Holding AG, Performance Chart (2015 - 2019)
  • Sonova Holding AG, Ratio Charts
  • Sonova Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
  • Sonova Holding AG, Medical Equipment, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diabetes Care Inc
  • Becton Dickinson and Co
  • Ascensia Diabetes Care US Inc
  • Medtronic Diabetes
  • LifeScan Inc
Note: Product cover images may vary from those shown
Adroll
adroll